Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM
Jan 14, 2026 08:06AM
Jan 14, 2026 08:05AM
Dec 22, 2025 08:05AM
Dec 22, 2025 08:05AM
Dec 10, 2025 08:05AM SCIENTURE partners with BlinkRx to expand access to Arbli oral suspension
Dec 10, 2025 08:05AM
Nov 13, 2025 08:05AM
Nov 4, 2025 08:05AM
Nov 4, 2025 08:05AM
Oct 23, 2025 08:05AM
Oct 23, 2025 08:05AM
Oct 1, 2025 09:00AM SCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli™ (losartan potassium) to more than 2500 Healthcare Institutions
Sep 16, 2025 08:05AM
Sep 16, 2025 08:05AM
Jul 16, 2025 08:15AM
Jul 16, 2025 08:15AM
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM
May 22, 2025 08:20AM Scienture Holdings (SCNX) CEO steps down
May 22, 2025 08:05AM
Apr 3, 2025 08:26AM
Apr 3, 2025 08:26AM
Mar 25, 2025 08:05AM
Mar 25, 2025 08:05AM
Mar 19, 2025 08:05AM
Dec 10, 2024 08:06AM Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through
Dec 10, 2024 08:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All